Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

In this review, combined post-mortem brain magnetic resonance imaging (MRI) and histology studies are highlighted, illustrating the relevance of translational approaches to define novel MRI signatures of neuropathological lesions in neuroinflammatory and neurodegenerative disorders. Initial studies combining post-mortem MRI and histology have validated various MRI sequences, assessing their sensitivity and specificity as diagnostic biomarkers in neurologic disease. More recent studies have focused on defining new radiological (bio)markers and implementing them in the clinical (research) setting. By combining neurological and neuroanatomical expertise with radiological development and pathological validation, a cycle emerges that allows for the discovery of novel MRI biomarkers to be implemented in vivo. Examples of this cycle are presented for multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Some applications have been shown to be successful, while others require further validation. In conclusion, there is much to explore with post-mortem MRI and histology studies, which can eventually be of high relevance for clinical practice.

LanguageEnglish
Pages229-243
Number of pages15
JournalNeuroscience Bulletin
Volume35
Issue number2
DOIs
Publication statusPublished - 2 Apr 2019

Cite this

@article{16086ba7a90f418e8b82898d21491e63,
title = "Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach",
abstract = "In this review, combined post-mortem brain magnetic resonance imaging (MRI) and histology studies are highlighted, illustrating the relevance of translational approaches to define novel MRI signatures of neuropathological lesions in neuroinflammatory and neurodegenerative disorders. Initial studies combining post-mortem MRI and histology have validated various MRI sequences, assessing their sensitivity and specificity as diagnostic biomarkers in neurologic disease. More recent studies have focused on defining new radiological (bio)markers and implementing them in the clinical (research) setting. By combining neurological and neuroanatomical expertise with radiological development and pathological validation, a cycle emerges that allows for the discovery of novel MRI biomarkers to be implemented in vivo. Examples of this cycle are presented for multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Some applications have been shown to be successful, while others require further validation. In conclusion, there is much to explore with post-mortem MRI and histology studies, which can eventually be of high relevance for clinical practice.",
keywords = "Alzheimer’s disease, Biomarkers, Histology, MRI, Multiple sclerosis, Parkinson’s disease",
author = "Jonkman, {Laura E.} and Boyd Kenkhuis and Geurts, {Jeroen J.G.} and {van de Berg}, {Wilma D.J.}",
year = "2019",
month = "4",
day = "2",
doi = "10.1007/s12264-019-00342-3",
language = "English",
volume = "35",
pages = "229--243",
journal = "Neuroscience Bulletin",
issn = "1673-7067",
publisher = "Springer Singapore",
number = "2",

}

Post-Mortem MRI and Histopathology in Neurologic Disease : A Translational Approach. / Jonkman, Laura E.; Kenkhuis, Boyd; Geurts, Jeroen J.G.; van de Berg, Wilma D.J.

In: Neuroscience Bulletin, Vol. 35, No. 2, 02.04.2019, p. 229-243.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Post-Mortem MRI and Histopathology in Neurologic Disease

T2 - Neuroscience Bulletin

AU - Jonkman, Laura E.

AU - Kenkhuis, Boyd

AU - Geurts, Jeroen J.G.

AU - van de Berg, Wilma D.J.

PY - 2019/4/2

Y1 - 2019/4/2

N2 - In this review, combined post-mortem brain magnetic resonance imaging (MRI) and histology studies are highlighted, illustrating the relevance of translational approaches to define novel MRI signatures of neuropathological lesions in neuroinflammatory and neurodegenerative disorders. Initial studies combining post-mortem MRI and histology have validated various MRI sequences, assessing their sensitivity and specificity as diagnostic biomarkers in neurologic disease. More recent studies have focused on defining new radiological (bio)markers and implementing them in the clinical (research) setting. By combining neurological and neuroanatomical expertise with radiological development and pathological validation, a cycle emerges that allows for the discovery of novel MRI biomarkers to be implemented in vivo. Examples of this cycle are presented for multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Some applications have been shown to be successful, while others require further validation. In conclusion, there is much to explore with post-mortem MRI and histology studies, which can eventually be of high relevance for clinical practice.

AB - In this review, combined post-mortem brain magnetic resonance imaging (MRI) and histology studies are highlighted, illustrating the relevance of translational approaches to define novel MRI signatures of neuropathological lesions in neuroinflammatory and neurodegenerative disorders. Initial studies combining post-mortem MRI and histology have validated various MRI sequences, assessing their sensitivity and specificity as diagnostic biomarkers in neurologic disease. More recent studies have focused on defining new radiological (bio)markers and implementing them in the clinical (research) setting. By combining neurological and neuroanatomical expertise with radiological development and pathological validation, a cycle emerges that allows for the discovery of novel MRI biomarkers to be implemented in vivo. Examples of this cycle are presented for multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury. Some applications have been shown to be successful, while others require further validation. In conclusion, there is much to explore with post-mortem MRI and histology studies, which can eventually be of high relevance for clinical practice.

KW - Alzheimer’s disease

KW - Biomarkers

KW - Histology

KW - MRI

KW - Multiple sclerosis

KW - Parkinson’s disease

UR - http://www.scopus.com/inward/record.url?scp=85061959735&partnerID=8YFLogxK

U2 - 10.1007/s12264-019-00342-3

DO - 10.1007/s12264-019-00342-3

M3 - Review article

VL - 35

SP - 229

EP - 243

JO - Neuroscience Bulletin

JF - Neuroscience Bulletin

SN - 1673-7067

IS - 2

ER -